Literature DB >> 19843397

Lymphatic filariasis: patients and the global elimination programme.

C D Mackenzie1, W M Lazarus, M E Mwakitalu, U Mwingira, M N Malecela.   

Abstract

The defining images of lymphatic filariasis are the horrendous disfigurements of lymphoedema, elephantiasis and hydrocele. These clinical presentations, although obviously important and life changing, are not, however, the only outcomes of this wide-spread filarial infection. The other effects of the disease range from severe, acute but short-term bouts of sickness to psychological impairment, poverty and family hardship. It is important to support cases of the disease through all means available, such as reparative hydrocelectomy, hygiene training and facilitation, and the provision of adequate chemotherapy. Although only a minority of the residents in any endemic community is affected with the severe clinical manifestations of this parasitic infection, these cases are central to, and important advocates for, the current global effort to eliminate the infection through mass drug administrations (MDA). Their clinical improvement acts as an important catalyst for the general population and encourages high compliance in the MDA. This communication discusses the central role that filariasis patients have played in the Tanzania Lymphatic Filariasis Elimination Programme to date, and covers some of the clinical successes achieved in the past 10 years. The abolition of the clinical manifestations of filarial infection remains the ultimate goal of the Global Programme to Eliminate Lymphatic Filariasis, and maintaining a focus on the affected individuals and their clinical condition is vital to that programme's overall success.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843397     DOI: 10.1179/000349809X12502035776630

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  14 in total

1.  Jaboulay's technique contrasted with a novel hydrocelectomy technique using a vessel sealer in the treatment of adult hydrocele: a prospective randomized study.

Authors:  Fatih Ozkaya; Ozer Ural Cakici
Journal:  Int Urol Nephrol       Date:  2019-11-27       Impact factor: 2.370

2.  Urologic disease in a resource-poor country.

Authors:  Marc Manganiello; Christopher D Hughes; Lars Hagander; David Bayne; Jean Hamiltong Pierre; Jill C Buckley; John G Meara
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

3.  A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).

Authors:  Hugo C Turner; Eric A Ottesen; Mark H Bradley
Journal:  Parasit Vectors       Date:  2022-05-28       Impact factor: 4.047

4.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

5.  The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.

Authors:  David Addiss
Journal:  Parasit Vectors       Date:  2010-10-20       Impact factor: 3.876

6.  Monitoring mosquitoes in urban Dar es Salaam: evaluation of resting boxes, window exit traps, CDC light traps, Ifakara tent traps and human landing catches.

Authors:  Nicodem J Govella; Prosper P Chaki; John M Mpangile; Gerry F Killeen
Journal:  Parasit Vectors       Date:  2011-03-21       Impact factor: 3.876

7.  Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system.

Authors:  Upendo Mwingira; Maria Chikawe; Wilfred Lazarus Mandara; Hayley E Mableson; Cecilia Uisso; Irene Mremi; Alpha Malishee; Mwele Malecela; Charles D Mackenzie; Louise A Kelly-Hope; Michelle C Stanton
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

Review 8.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

9.  Global programme to eliminate lymphatic filariasis: the processes underlying programme success.

Authors:  Kazuyo Ichimori; Jonathan D King; Dirk Engels; Aya Yajima; Alexei Mikhailov; Patrick Lammie; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

10.  The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).

Authors:  Hugo C Turner; Alison A Bettis; Brian K Chu; Deborah A McFarland; Pamela J Hooper; Eric A Ottesen; Mark H Bradley
Journal:  Infect Dis Poverty       Date:  2016-05-24       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.